An interventional study of Lithotripter in Kidney Stone, Kidney Calculi and Ureteral Calculi, sponsored by The Cleveland Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-13.
Sponsored by The Cleveland Clinic · Not applicable, Interventional, and Treatment
A comparison on the outcomes of patients undergoing shockwave lithotripsy using the Storz machine versus the Dornier machine.
This is a single institution, prospective randomized controlled clinical trial comparing two lithotriper machines (the Storz Modulith LX-F2 and Dornier Delta III) in patients who are undergoing shockwave lithotripsy (SWL) as the primary management of their urinary stone. Patients record pain score on day of operation and post-operative day 1, and are followed for 1 month until they receive standard of care imaging at 1 month post-operatively.
509 studies on the registry are indexed under Kidney Calculi; 146 are open to participants now.
This study's enrollment of 6 is below the median of 86 across 391 interventional studies indexed under Kidney Calculi.
Browse Kidney Calculi studies →The Cleveland Clinic is the lead sponsor of 831 studies on the registry; 119 are open to participants now.
Of its 90 completed or terminated interventional studies of FDA-regulated products, 73 (81%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients must be capable of giving and must be capable and willing to enroll and participate fully with the study.
Exclusion Criteria:
Prior treatment for specified stone
Patients unable to give or unwilling to enroll or participate in the study will be excluded.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients receive standard of care treatment for their urolithiasis using the Device Storz Modulith SLX-F2
Procedure: Lithotripter
Patients receive standard of care treatment for their urolithiasis using the Dornier Delta III lithotripter
Procedure: Lithotripter
Patients receive standard of care treatment for their urolithiasis using one of two lithotripter machines
Stone free rate
Presence of stone on follow up imaging
Time frame: Four weeks post operative
Fluoroscopy time
Length of fluoroscopy exposure
Time frame: Intra-operative
Treatment Time
Length of surgical procedure
Time frame: Intra-operative
Pain Scores
Response to visual analog scale
Time frame: Four days post-operative
Complication Rates
Medical complications
Time frame: One month post-operative
Secondary Interventions required
Follow up surgery
Time frame: One month post-operative
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.